BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,710,845 | -37.1% | 230,812 | -24.1% | 0.09% | -47.3% |
| Q2 2023 | $13,850,969 | +162451.0% | 304,016 | +44.7% | 0.16% | +25.0% |
| Q1 2023 | $8,521 | -53.0% | 210,081 | -40.9% | 0.13% | -63.1% |
| Q4 2022 | $18,127 | -95.5% | 355,620 | +4705.7% | 0.36% | +3877.8% |
| Q3 2022 | $399,000 | -51.5% | 7,400 | -42.2% | 0.01% | -59.1% |
| Q2 2022 | $823,000 | -81.7% | 12,811 | -77.9% | 0.02% | -79.0% |
| Q1 2022 | $4,501,000 | -4.5% | 58,042 | -0.9% | 0.10% | +18.0% |
| Q2 2021 | $4,713,000 | +254.9% | 58,548 | +254.6% | 0.09% | +53.4% |
| Q3 2020 | $1,328,000 | -77.9% | 16,510 | -77.1% | 0.06% | -78.5% |
| Q4 2019 | $6,019,000 | +185.0% | 71,977 | +151.6% | 0.27% | +264.9% |
| Q2 2018 | $2,112,000 | -45.2% | 28,606 | -51.7% | 0.07% | -40.8% |
| Q1 2018 | $3,854,000 | +471.0% | 59,258 | +467.7% | 0.12% | +635.3% |
| Q4 2017 | $675,000 | +44.5% | 10,439 | +40.1% | 0.02% | +41.7% |
| Q3 2017 | $467,000 | -65.2% | 7,450 | -71.2% | 0.01% | -70.7% |
| Q1 2017 | $1,342,000 | -8.0% | 25,876 | -21.4% | 0.04% | +7.9% |
| Q4 2016 | $1,459,000 | -7.6% | 32,911 | -0.8% | 0.04% | +2.7% |
| Q3 2016 | $1,579,000 | +27.1% | 33,174 | +20.8% | 0.04% | +42.3% |
| Q2 2016 | $1,242,000 | -53.3% | 27,459 | -57.5% | 0.03% | -61.8% |
| Q1 2016 | $2,657,000 | -12.8% | 64,681 | -19.0% | 0.07% | -20.0% |
| Q4 2015 | $3,048,000 | +16.1% | 79,893 | -0.0% | 0.08% | -4.5% |
| Q3 2015 | $2,626,000 | -64.3% | 79,931 | -24.1% | 0.09% | -58.6% |
| Q2 2015 | $7,366,000 | +102.9% | 105,328 | +98.7% | 0.22% | +85.3% |
| Q1 2015 | $3,631,000 | +407.8% | 53,009 | +443.4% | 0.12% | +364.0% |
| Q4 2014 | $715,000 | +4.4% | 9,755 | +2.3% | 0.02% | 0.0% |
| Q3 2014 | $685,000 | -38.9% | 9,539 | -38.5% | 0.02% | -41.9% |
| Q2 2014 | $1,121,000 | +138.0% | 15,503 | +142.2% | 0.04% | +115.0% |
| Q1 2014 | $471,000 | +21.1% | 6,400 | +14.3% | 0.02% | +5.3% |
| Q4 2013 | $389,000 | -54.1% | 5,600 | -56.6% | 0.02% | -45.7% |
| Q3 2013 | $847,000 | -96.8% | 12,900 | -96.6% | 0.04% | -98.2% |
| Q2 2013 | $26,551,000 | – | 383,300 | – | 1.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |